Molecular pathological analysis of citrullinated proteins in the brain from neurodegenerative disorder patients.
神经退行性疾病患者大脑中瓜氨酸蛋白的分子病理学分析。
基本信息
- 批准号:14570210
- 负责人:
- 金额:$ 2.11万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Citrullinated proteins are the products of a post-translational process in which arginine residues undergo modification into citrulline residues when catalyzed by peptidylarginine deiminases(PADs) in a calcium ion-dependent manner. Enzymatic citrullination abolishes positive charges of native protein molecules, inevitably causing significant alterations in their structure and functions. In mammalian tissues, PADs are found as five different isoforms (i.e, types 1-4,6). PAD2 expressed mainly in the rat cerebrum became activated early in the neurodegenerative process. To elucidate the involvement of the citrullination in neuronal degeneration, we examined whether citrullinated proteins are produced in Alzheimer's disease(AD), Parkinson's disease, and Huntington chorea.1.Histochemical analysis revealed that citrullinated proteins were detected all over the hippocampus. However, no citrullinated proteins were detected in the normal hippocampus. PAD2 immunoreactivity was also detected all over the hippocampus both in the AD and the normal brain. Double immunofluorescence staining revealed that citrullinated protein- and PAD2-positive cells were well-coinddenced with GFAP-positive cells, but not all GFAP-positive cells were PAD2-positive cells. As GFAP is a astrocyte-spedfic marker protein, PAD2 is distributed mainly in astrocytes.2.Citrullinated proteins with various molecular weight were detected in AD hippocampus by Western blot analysis, but not in normal brain. Two of the citrullinated proteins were identified as a vimentin and a glial fibrillary acidic protein(GFAP).Thus, abnormal accumulation of citrullinated proteins and abnormal activation of PAD2 is occurring in AD hippocampus. These results strongly suggested that PAD has an important role in the onset and progression of AD and citrullinated proteins may became a possible useful marker for human neurodegenerative disease.
瓜氨酸蛋白是翻译后过程的产物,其中精氨酸残基在肽基精氨酸脱亚胺酶 (PAD) 以钙离子依赖性方式催化时修饰为瓜氨酸残基。酶促瓜氨酸化消除了天然蛋白质分子的正电荷,不可避免地导致其结构和功能发生显着改变。在哺乳动物组织中,PAD 有五种不同的亚型(即 1-4,6 型)。 PAD2 主要在大鼠大脑中表达,在神经退行性过程的早期被激活。为了阐明瓜氨酸化在神经元变性中的作用,我们检查了阿尔茨海默病(AD)、帕金森病和亨廷顿舞蹈病是否产生瓜氨酸蛋白。1.组织化学分析显示,在整个海马体中都检测到了瓜氨酸蛋白。然而,在正常海马中没有检测到瓜氨酸蛋白。在 AD 和正常大脑的整个海马体中也检测到了 PAD2 免疫反应性。双重免疫荧光染色显示瓜氨酸蛋白和 PAD2 阳性细胞与 GFAP 阳性细胞高度一致,但并非所有 GFAP 阳性细胞都是 PAD2 阳性细胞。由于GFAP是星形胶质细胞特有的标记蛋白,PAD2主要分布在星形胶质细胞中。2.Western blot检测AD海马中检测到不同分子量的瓜氨酸蛋白,而正常脑中未检测到。其中两种瓜氨酸蛋白被鉴定为波形蛋白和神经胶质纤维酸性蛋白(GFAP)。因此,AD海马中出现了瓜氨酸蛋白的异常积累和PAD2的异常激活。这些结果强烈表明,PAD 在 AD 的发生和进展中具有重要作用,瓜氨酸蛋白可能成为人类神经退行性疾病的可能有用标记。
项目成果
期刊论文数量(39)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Protein deimination and peptidylarginine deiminase expression during cornification of rat epidermal keratinocytes.
大鼠表皮角质形成细胞角质化过程中的蛋白质脱亚胺化和肽基精氨酸脱亚胺酶表达。
- DOI:
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:Ishigami;A.;Asaga;H.;et al.
- 通讯作者:et al.
Senescence marker protein-30 (SMP30) regulates Akt activity and contributes to cell survival in Hep G2 cells.
衰老标记蛋白 30 (SMP30) 调节 Akt 活性并有助于 Hep G2 细胞的细胞存活。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Matsuyama;S.;Kitamura;T.;Enomoto;N.;Fujita;T.et al.
- 通讯作者:T.et al.
Abnormal accumulation of deiminated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.
阿尔茨海默病患者海马提取物中肽基精氨酸脱亚胺酶催化的脱亚胺蛋白异常积累。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Ishigami;A;Ohsawa;T;Hiratsuka;M;Taguchi;H;Kobayashi;S;Saito;Y;Murayama;S;Asaga;H;Toda;T;Kimura;N.Maruyama;N.
- 通讯作者:N.
Mori, T., Ishigami, A.et al.: "Senescence marker protein-30 knockout mouse as a novel murine model of senile lung."Pathol.Int.. 54. 167-173 (2004)
Mori, T., Ishigami, A.等人:“衰老标记蛋白 30 敲除小鼠作为老年肺的新型小鼠模型。”Pathol.Int.. 54. 167-173 (2004)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I
- DOI:10.1042/bj20020870
- 发表时间:2003-02-15
- 期刊:
- 影响因子:4.1
- 作者:Guerrin, M;Ishigami, A;Serre, G
- 通讯作者:Serre, G
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ISHIGAMI Akihito其他文献
High-Dose Vitamin C Preadministration Reduces Vancomycin-Associated Nephrotoxicity in Mice
预先给予高剂量维生素 C 可降低小鼠万古霉素相关的肾毒性
- DOI:
10.3177/jnsv.65.399 - 发表时间:
2019 - 期刊:
- 影响因子:1.6
- 作者:
TAKIGAWA Masaki;YATSU Tomofumi;TAKINO Yuka;MATSUMOTO Shigekiyo;KITANO Takaaki;LEE Jaewon;ARAI Tomio;TANAKA Hiroyuki;ISHII Toshihiro;MORI Yoshiko;ISHIGAMI Akihito - 通讯作者:
ISHIGAMI Akihito
Acerola (<i>Malpighia emarginata</i> DC.) Promotes Ascorbic Acid Uptake into Human Intestinal Caco-2 Cells via Enhancing the Gene Expression of Sodium-Dependent Vitamin C Transporter 1
针叶樱桃 (<i>Malpighia emarginata</i> DC.) 通过增强钠依赖性维生素 C 转运蛋白 1 的基因表达促进人肠 Caco-2 细胞吸收抗坏血酸
- DOI:
10.3177/jnsv.66.296 - 发表时间:
2020 - 期刊:
- 影响因子:1.6
- 作者:
TAKINO Yuka;AOKI Hitoshi;KONDO Yoshitaka;ISHIGAMI Akihito - 通讯作者:
ISHIGAMI Akihito
Effects of aging and sex differences on IGF-2 and myostatin gene expressions in rat skeletal muscle following resistance training.
抗阻训练后衰老和性别差异对大鼠骨骼肌 IGF-2 和肌生长抑制素基因表达的影响。
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
HUNG Yung-Li;SATO Ayami;TAKINO Yuka;ISHIGAMI Akihito;MACHIDA Shuichi - 通讯作者:
MACHIDA Shuichi
ISHIGAMI Akihito的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ISHIGAMI Akihito', 18)}}的其他基金
Development of diagnostic agent for dementia
痴呆症诊断剂的开发
- 批准号:
24659169 - 财政年份:2012
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Effect of vitamin C deficiency on the fetal growth and aging
维生素C缺乏对胎儿生长和衰老的影响
- 批准号:
24380073 - 财政年份:2012
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Pathogenesis and drug development using a mouse model of chronic obstructive pulmonary disease
使用慢性阻塞性肺疾病小鼠模型的发病机制和药物开发
- 批准号:
21590974 - 财政年份:2009
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The elucidation of onset mechanism of Alzheimer's disease.
阐明阿尔茨海默病的发病机制。
- 批准号:
18590355 - 财政年份:2006
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
阿尔茨海默病早期认知功能下降病情演化临界预警模型研究
- 批准号:82371484
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于空间代谢流技术探究人参-远志药对通过纠偏单胺类神经递质代谢紊乱治疗阿尔茨海默病的整合作用模式
- 批准号:82304894
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SETDB1调控小胶质细胞功能及参与阿尔茨海默病发病机制的研究
- 批准号:82371419
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
小胶质细胞特异罕见易感突变介导相分离影响阿尔茨海默病发病风险的机制
- 批准号:82371438
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
GFAP-C291棕榈酰化激活星型胶质细胞在阿尔茨海默病中的作用和机制及干预研究
- 批准号:32371309
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Discovering early biomarkers of Alzheimer's disease using genetic and physics-informed networks
利用遗传和物理信息网络发现阿尔茨海默病的早期生物标志物
- 批准号:
2904538 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Studentship
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Operating Grants
Deciphering electrophysiological Alzheimer's Disease biomarkers for early diagnosis using interpretable deep learning
使用可解释的深度学习破译电生理阿尔茨海默病生物标志物以进行早期诊断
- 批准号:
24K18602 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigating And Targeting Microglial Senescence In Alzheimer's Disease
研究并针对阿尔茨海默病中的小胶质细胞衰老
- 批准号:
MR/Y004116/1 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Research Grant
DMS/NIGMS 1: Multilevel stochastic orthogonal subspace transformations for robust machine learning with applications to biomedical data and Alzheimer's disease subtyping
DMS/NIGMS 1:多级随机正交子空间变换,用于稳健的机器学习,应用于生物医学数据和阿尔茨海默病亚型分析
- 批准号:
2347698 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Continuing Grant